Home

OrbiMed Capital GP VIII, 10% Owner: Traws Pharma TRAW Buy · Filed 04/28

Trade details

Type
Insider buy
Amount
$998,207.43
Shares · price
597,729 sh · $1.67 a share
Held after
1,203,250 sh
Trade date
26/04/16
Filed
26/04/28
Days to filing
12 days

First buy since 2023

Insiders buying this week
2 insiders
Holding change
+98.7%

Traws Pharma trades, last 26 weeks

What else happened in Traws Pharma around then

Filed or reported within 30 days of the trade day · 03/17~05/16

OrbiMed Capital GP VIII's recent trades

  • OrbiMed Capital GP VIII

    Sell10b5-1 planSionna Therapeutics

    $4,493

    Filed 05/29

  • OrbiMed Capital GP VIII

    Sell10b5-1 planSionna Therapeutics

    $8.5M

    Filed 05/11

  • OrbiMed Capital GP VIII

    Sell10b5-1 planSionna Therapeutics

    $2.7M

    Filed 05/11

  • OrbiMed Capital GP VIII

    Sell10b5-1 planSionna Therapeutics

    $2.2M

    Filed 05/11

  • OrbiMed Capital GP VIII

    Sell10b5-1 planSionna Therapeutics

    $2.3M

    Filed 04/21